COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I REGNREGN LY-CoVLY RemdesivirRMD
HCQ study #211 of 237
12/14 Late treatment study
Naseem et al., medRxiv, doi:10.1101/2020.12.13.20247254 (Preprint)
Predicting mortality in SARS-COV-2 (COVID-19) positive patients in the inpatient setting using a Novel Deep Neural Network
Source   PDF   Share   Tweet
Retrospective 1,214 hospitalized patients in Pakistan, 77 HCQ patients, showing 33% lower mortality with HCQ, multivariate Cox HR 0.67, p = 0.34.

Naseem et al., 12/14/2020, retrospective, Pakistan, South Asia, preprint, 5 authors.
risk of death, 33.3% lower, RR 0.67, p = 0.34, treatment 77, control 1137, multivariate Cox.
Details of all 237 studies    Meta analysis
Please send us corrections, updates, or comments.